Antiarrhythmic Drug Therapy for Ventricular Arrhythmias: The Changing Role in the Modern Era

被引:0
|
作者
Cuk, Natasha [1 ]
Braunstein, Eric. D. D. [1 ,2 ]
机构
[1] Smidt Heart Inst, Cedars Sinai Med Ctr, Dept Cardiol, Los Angeles, CA USA
[2] Smidt Heart Inst, Cedars Sinai Med Ctr, 127 S San Vicente Blvd, Suite A3600, Los Angeles, CA 90048 USA
关键词
ventricular arrhythmias; ventricular tachycardia; antiarrhythmic drugs; catheter ablation; ABLATION;
D O I
10.1159/000529968
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antiarrhythmic drugs (AADs) are powerful tools for suppression of ventricular arrhythmias (VAs). In the modern era, the role of AADs has evolved from the primary method of prevention of sudden cardiac death to an important element of multimodality treatment of VAs that can include medications, cardiac implantable electronic devices, and catheter-based ablation procedures. In this editorial, we discuss the changing role of AADs, and how they fit into the quickly evolving arena of intervention available for VAs.
引用
收藏
页码:131 / 133
页数:3
相关论文
共 50 条
  • [41] Antiarrhythmic Therapy of Asymptomatic Arrhythmias
    Gonska, Bernd-Dieter
    AKTUELLE KARDIOLOGIE, 2018, 7 (06) : 436 - 442
  • [42] Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
    Gaine, Sean P.
    Calkins, Hugh
    BIOMEDICINES, 2023, 11 (04)
  • [43] Antiarrhythmic drug therapy for ventricular arrhythmia: Current perspectives
    Link, MS
    Homoud, M
    Foote, CB
    Wang, PJ
    Estes, NAM
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1996, 7 (07) : 653 - 670
  • [44] Current and Emerging Antiarrhythmic Drug Therapy for Ventricular Tachycardia
    Williams E.S.
    Viswanathan M.N.
    Cardiology and Therapy, 2013, 2 (1) : 27 - 46
  • [45] COMBINATION ANTIARRHYTHMIC DRUG-THERAPY FOR VENTRICULAR TACHYARRHYTHMIAS
    GREENSPAN, AM
    SPIELMAN, SR
    HOROWITZ, LN
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1986, 9 (04): : 565 - 576
  • [46] SUDDEN CARDIAC DEATH, VENTRICULAR ARRHYTHMIAS, AND ANTIARRHYTHMIC THERAPY - CURRENT TRIALS AND TRIBULATIONS
    ANDERSON, JL
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1986, 16 (03): : 409 - 412
  • [47] Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy
    Cappelletto, Chiara
    Gregorio, Caterina
    Barbati, Giulia
    Romani, Simona
    De Luca, Antonio
    Merlo, Marco
    Mestroni, Luisa
    Stolfo, Davide
    Sinagra, Gianfranco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 334 : 58 - 64
  • [48] A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
    McAnulty, J
    Halperin, B
    Kron, J
    Larsen, G
    Raitt, M
    Swenson, R
    Florek, R
    Marchant, C
    Hamlin, M
    Heywood, G
    Friedman, P
    Stevenson, W
    Swat, M
    Ganz, L
    Sweeney, M
    Shea, J
    Steinberg, J
    Ehlert, F
    Zelenkofske, S
    MenchavezTan, E
    DeStefano, M
    Brown, G
    Anderson, J
    Karagounis, L
    Crandall, B
    Osborn, J
    Rawling, D
    Summers, K
    Jacobsen, M
    Herre, J
    Bernstein, R
    Klevan, L
    Cannon, D
    Bhandari, A
    Lerman, R
    Firth, B
    Klein, R
    Freedman, R
    Marks, M
    Delahunty, M
    Spratt, C
    Marinchak, R
    Rials, S
    Kowey, P
    Filart, R
    Hernandez, M
    Scher, D
    Zukerman, L
    Farrell, S
    Kolk, D
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (22): : 1576 - 1583
  • [49] ADVANCES IN ANTIARRHYTHMIC DRUG-THERAPY - CHANGING CONCEPTS - INTRODUCTION
    KAPLAN, HR
    FEDERATION PROCEEDINGS, 1986, 45 (08) : 2184 - 2185
  • [50] ANTIARRHYTHMIC DRUG-THERAPY - NEW DRUGS AND CHANGING CONCEPTS
    REISER, HJ
    SULLIVAN, ME
    FEDERATION PROCEEDINGS, 1986, 45 (08) : 2206 - 2212